A common point of confusion is brand versus generic naming
It also contributes to skin clarity and overall cellular health
Effectiveness: Average weight loss: 510% of body weight Often used short-term, under medical supervision Considerations: Possible side effects: insomnia, dry mouth, dizziness Should not be used with certain antidepressants or in people with heart issues 3
The British Menopause Society advises considering transdermal options, like patches or gels, which bypass the digestive system and maintain more stable hormone levels
Vasoconstriction is caused by noradrenaline activated alpha-1 adrenergic receptor released from sympathetic ganglion neurons
The studys methodology and findings revealed data points: Among 710 type 2 diabetes patients, 17 semaglutide users developed NAION versus only 6 non-users, despite similar baseline characteristics In the weight loss cohort of 979 patients, NAION occurred in 20 semaglutide users compared to 3 in the control group Cumulative NAION incidence over 36 months reached 8.9% for diabetic semaglutide users versus 1.8% for non-GLP-1 medications Weight loss patients showed 6.7% NAION incidence with semaglutide versus 0.8% without Manual chart review by neuro-ophthalmology specialists ensured diagnostic accuracy often lacking in larger database studies Risk persisted after controlling for known NAION risk factors including age, sex, hypertension, and sleep apnea The biological plausibility of semaglutide-induced NAION stems from multiple proposed mechanisms that researchers continue investigating
